{"id":"https://openalex.org/W4206961663","doi":"https://doi.org/10.1093/infdis/jiac016","title":"SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial","display_name":"SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial","publication_year":2022,"publication_date":"2022-01-24","ids":{"openalex":"https://openalex.org/W4206961663","doi":"https://doi.org/10.1093/infdis/jiac016","pmid":"https://pubmed.ncbi.nlm.nih.gov/35079784","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8807286"},"language":"en","primary_location":{"id":"doi:10.1093/infdis/jiac016","doi":"https://doi.org/10.1093/infdis/jiac016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/infdis/jiac016","pdf_url":"https://academic.oup.com/jid/article-pdf/225/11/1923/43918241/jiac016.pdf","source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jid/article-pdf/225/11/1923/43918241/jiac016.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071608389","display_name":"Kimberly Ann Kraynyak","orcid":"https://orcid.org/0000-0001-9233-8858","observed_orcids":["https://orcid.org/0000-0001-9233-8858"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly A Kraynyak","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085673982","display_name":"Elliott Blackwood","orcid":"https://orcid.org/0000-0002-6777-9106","observed_orcids":["https://orcid.org/0000-0002-6777-9106"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elliott Blackwood","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063348319","display_name":"Joseph T. Agnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Agnes","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061630637","display_name":"Pablo Tebas","orcid":"https://orcid.org/0000-0001-5345-7942","observed_orcids":["https://orcid.org/0000-0001-5345-7942"]},"institutions":[{"id":"https://openalex.org/I2799810409","display_name":"Hospital of the University of Pennsylvania","ror":"https://ror.org/02917wp91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799810409","https://openalex.org/I4210143392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo Tebas","raw_affiliation_strings":["Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I2799810409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055556789","display_name":"Mary Giffear","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Giffear","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039875547","display_name":"Dinah H. Amante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dinah Amante","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049805385","display_name":"Emma L. Reuschel","orcid":"https://orcid.org/0000-0002-4627-1354","observed_orcids":["https://orcid.org/0000-0002-4627-1354"]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emma L Reuschel","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047272629","display_name":"Mansi Purwar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mansi Purwar","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060301604","display_name":"Aaron Christensen-Quick","orcid":"https://orcid.org/0000-0002-1477-4571","observed_orcids":["https://orcid.org/0000-0002-1477-4571"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Christensen-Quick","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084077730","display_name":"Neiman Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neiman Liu","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086923009","display_name":"Viviane M. Andrade","orcid":"https://orcid.org/0000-0002-5056-298X","observed_orcids":["https://orcid.org/0000-0002-5056-298X"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viviane M Andrade","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079743464","display_name":"Malissa C. Diehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malissa C Diehl","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067264538","display_name":"Snehal Wani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Snehal Wani","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087489552","display_name":"Martyna \u0141upicka","orcid":"https://orcid.org/0000-0003-4161-0959","observed_orcids":["https://orcid.org/0000-0003-4161-0959"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martyna Lupicka","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025867351","display_name":"Albert J. Sylvester","orcid":"https://orcid.org/0000-0002-4087-9596","observed_orcids":["https://orcid.org/0000-0002-4087-9596"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert Sylvester","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045028558","display_name":"Matthew P. Morrow","orcid":"https://orcid.org/0000-0003-0258-6095","observed_orcids":["https://orcid.org/0000-0003-0258-6095"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew P Morrow","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014410261","display_name":"Patrick Pezzoli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Pezzoli","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015377056","display_name":"Trevor McMullan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevor McMullan","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026500170","display_name":"Abhijeet J. Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhijeet J Kulkarni","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080138775","display_name":"Faraz I. Zaidi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Faraz I Zaidi","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067654467","display_name":"Drew M. Frase","orcid":"https://orcid.org/0000-0003-3129-4673","observed_orcids":["https://orcid.org/0000-0003-3129-4673"]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Drew Frase","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044965964","display_name":"Kevin Liaw","orcid":"https://orcid.org/0000-0002-8235-1407","observed_orcids":["https://orcid.org/0000-0002-8235-1407"]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Liaw","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053501389","display_name":"Trevor R.F. Smith","orcid":"https://orcid.org/0000-0002-0671-2565","observed_orcids":["https://orcid.org/0000-0002-0671-2565"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevor R F Smith","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067942048","display_name":"Stephanie J. Ramos","orcid":"https://orcid.org/0000-0002-5326-4937","observed_orcids":["https://orcid.org/0000-0002-5326-4937"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie J Ramos","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071885632","display_name":"John E. Ervin","orcid":"https://orcid.org/0000-0002-9923-0572","observed_orcids":["https://orcid.org/0000-0002-9923-0572"]},"institutions":[{"id":"https://openalex.org/I4210109737","display_name":"Alliance for Multispecialty Research (United States)","ror":"https://ror.org/01dg1k785","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Ervin","raw_affiliation_strings":["Alliance for Multispecialty Research , Kansas City, Missouri , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance for Multispecialty Research , Kansas City, Missouri , USA","institution_ids":["https://openalex.org/I4210109737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014431860","display_name":"Mark E. Adams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109737","display_name":"Alliance for Multispecialty Research (United States)","ror":"https://ror.org/01dg1k785","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Adams","raw_affiliation_strings":["Alliance for Multispecialty Research , Lexington, Kentucky , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance for Multispecialty Research , Lexington, Kentucky , USA","institution_ids":["https://openalex.org/I4210109737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108052564","display_name":"Jessica L. Lee","orcid":"https://orcid.org/0000-0003-1711-9481","observed_orcids":["https://orcid.org/0000-0003-1711-9481"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Lee","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112655655","display_name":"Michael J. Dallas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Dallas","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024999374","display_name":"Ami Shah Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ami Shah Brown","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110810464","display_name":"Jacqueline E. Shea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline E Shea","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012244788","display_name":"J. Joseph Kim","orcid":"https://orcid.org/0000-0002-1515-6660","observed_orcids":["https://orcid.org/0000-0002-1515-6660"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Joseph Kim","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023265367","display_name":"David B. Weiner","orcid":"https://orcid.org/0000-0002-2232-8512","observed_orcids":["https://orcid.org/0000-0002-2232-8512"]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B Weiner","raw_affiliation_strings":["Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine and Immunotherapy Center, Wistar Institute , Philadelphia, Pennsylvania , USA","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062840115","display_name":"Kate E. Broderick","orcid":"https://orcid.org/0000-0003-2682-2363","observed_orcids":["https://orcid.org/0000-0003-2682-2363"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate E Broderick","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015488396","display_name":"Laurent M. P. F. Humeau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Laurent M Humeau","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067843924","display_name":"Jean Boyer","orcid":"https://orcid.org/0000-0001-8699-0532","observed_orcids":["https://orcid.org/0000-0001-8699-0532"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean D Boyer","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071688058","display_name":"Mammen P. Mammen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mammen P Mammen","raw_affiliation_strings":["Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovio Pharmaceuticals , Plymouth Meeting, Pennsylvania , USA","institution_ids":["https://openalex.org/I4210137215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5015488396"],"corresponding_institution_ids":["https://openalex.org/I4210137215"],"apc_list":{"value":4320,"currency":"USD","value_usd":4320},"apc_paid":null,"fwci":7.1102,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.98218836,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"225","issue":"11","first_page":"1923","last_page":"1932"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.7940000295639038},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9929999709129333},{"id":"https://openalex.org/keywords/covid-19-vaccines","display_name":"COVID-19 vaccines","score":0.9309999942779541},{"id":"https://openalex.org/keywords/spike-protein-antigen","display_name":"spike protein antigen","score":0.7269999980926514},{"id":"https://openalex.org/keywords/homologous-booster","display_name":"homologous booster","score":0.9079999923706055},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.628000020980835},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8199999928474426},{"id":"https://openalex.org/keywords/t-cell-mediated-cytotoxicity","display_name":"T cell cytotoxicity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/electroporation","display_name":"electroporation","score":0.7630000114440918},{"id":"https://openalex.org/keywords/intradermal-vaccination","display_name":"intradermal vaccination","score":0.6650000214576721},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5838455557823181},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.5527111291885376},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5482937097549438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5231553316116333},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38946104049682617},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3698085844516754},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08008193969726562}],"mesh":[{"descriptor_ui":"D000071497","descriptor_name":"Immunogenicity, Vaccine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019444","descriptor_name":"Vaccines, DNA","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1093/infdis/jiac016","doi":"https://doi.org/10.1093/infdis/jiac016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/infdis/jiac016","pdf_url":"https://academic.oup.com/jid/article-pdf/225/11/1923/43918241/jiac016.pdf","source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"doi:10.1101/2021.10.06.21264584","doi":"https://doi.org/10.1101/2021.10.06.21264584","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2021.10.06.21264584","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/01/25/2021.10.06.21264584.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},{"id":"pmid:35079784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35079784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of infectious diseases","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:8807286","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8807286/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/infdis/jiac016","doi":"https://doi.org/10.1093/infdis/jiac016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/infdis/jiac016","pdf_url":"https://academic.oup.com/jid/article-pdf/225/11/1923/43918241/jiac016.pdf","source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G9000886976","display_name":"Training Program in Basic Cancer Research","funder_award_id":"T32CA009171","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320316471","display_name":"INOVIO Pharmaceuticals","ror":"https://ror.org/042s6y882"},{"id":"https://openalex.org/F4320316507","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4206961663.pdf","grobid_xml":"https://content.openalex.org/works/W4206961663.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1975936140","https://openalex.org/W2019896390","https://openalex.org/W2048600393","https://openalex.org/W2761417170","https://openalex.org/W2923460756","https://openalex.org/W2942484034","https://openalex.org/W3003877025","https://openalex.org/W3008443627","https://openalex.org/W3009335299","https://openalex.org/W3014901343","https://openalex.org/W3025521550","https://openalex.org/W3046194290","https://openalex.org/W3084879098","https://openalex.org/W3097960438","https://openalex.org/W3110973116","https://openalex.org/W3115068672","https://openalex.org/W3134372509","https://openalex.org/W3149674978","https://openalex.org/W3156886555","https://openalex.org/W3162025982","https://openalex.org/W3178778712","https://openalex.org/W3185137851","https://openalex.org/W3205516522","https://openalex.org/W3207803539","https://openalex.org/W3213552396","https://openalex.org/W4226283253","https://openalex.org/W6791466878","https://openalex.org/W6795393306","https://openalex.org/W6803712135"],"related_works":["https://openalex.org/W4200143683","https://openalex.org/W3115068672","https://openalex.org/W4410711984","https://openalex.org/W3162025982","https://openalex.org/W4406849865","https://openalex.org/W4226283253","https://openalex.org/W3204210860","https://openalex.org/W3134372509","https://openalex.org/W4281649224","https://openalex.org/W3045651291"],"abstract_inverted_index":{"BACKGROUND:":[0],"Additional":[1],"severe":[2],"acute":[3],"respiratory":[4],"syndrome":[5],"coronavirus":[6,26],"2":[7,40],"(SARS-CoV-2)":[8],"vaccines":[9,17],"that":[10],"are":[11],"safe":[12],"and":[13,18,34,43,68,87,116,124,150,176,197],"effective":[14],"as":[15,194],"primary":[16,41,174,195],"boosters":[19],"remain":[20],"urgently":[21],"needed":[22],"to":[23],"combat":[24],"the":[25,97,136,162],"disease":[27],"2019":[28],"(COVID-19)":[29],"pandemic.":[30],"We":[31],"describe":[32],"safety":[33],"durability":[35],"of":[36,48,62,80,190],"immune":[37,145],"responses":[38],"following":[39,135],"doses":[42],"a":[44,139,172],"homologous":[45,140,177],"booster":[46,93,141,178],"dose":[47,142,164],"an":[49,91],"investigational":[50],"DNA":[51],"vaccine":[52,196],"(INO-4800)":[53],"targeting":[54],"full-length":[55],"spike":[56],"antigen.":[57],"METHODS:":[58],"Three":[59],"dosage":[60],"strengths":[61],"INO-4800":[63,81,101,167,191],"(0.5":[64],"mg,":[65,67],"1.0":[66],"2.0":[69],"mg)":[70],"were":[71,114,158],"evaluated":[72],"in":[73,120,161,171,179],"120":[74],"age-stratified":[75],"healthy":[76],"adults.":[77],"Intradermal":[78],"injection":[79],"followed":[82],"by":[83],"electroporation":[84],"at":[85],"0":[86],"4":[88],"weeks":[89],"preceded":[90],"optional":[92],"6-10.5":[94],"months":[95,134],"after":[96],"second":[98,137],"dose.":[99],"RESULTS:":[100],"appeared":[102],"well":[103,169],"tolerated":[104,170],"with":[105,122,155],"no":[106],"treatment-related":[107],"serious":[108],"adverse":[109,112],"events.":[110],"Most":[111],"events":[113],"mild":[115],"did":[117],"not":[118],"increase":[119],"frequency":[121],"age":[123],"subsequent":[125],"dosing.":[126],"A":[127],"durable":[128],"antibody":[129],"response":[130],"was":[131,168],"observed":[132],"6":[133],"dose;":[138],"significantly":[143,159],"increased":[144,160],"responses.":[146],"Cytokine-producing":[147],"T":[148,153],"cells":[149,154],"activated":[151],"CD8+":[152],"lytic":[156],"potential":[157],"2.0-mg":[163],"group.":[165],"CONCLUSIONS:":[166],"2-dose":[173],"series":[175],"all":[180],"adults,":[181],"including":[182],"elderly":[183],"participants.":[184],"These":[185],"results":[186],"support":[187],"further":[188],"development":[189],"for":[192],"use":[193],"booster.":[198],"CLINICAL":[199],"TRIALS":[200],"REGISTRATION:":[201],"NCT04336410.":[202]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":19},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-01-26T00:00:00"}